ASCT may offer alternative for therapy for high-risk follicular lymphoma
(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin
Updated on: March 30,2024
14

ASCT may offer alternative for therapy for high-risk follicular lymphoma
(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin
Updated on:March 30,2024
14
